Roivant Sciences (ROIV) total debt

Total debt · fiscal 2026
$107.44M

Roivant Sciences (ROIV) carried total debt of $107.44M at the end of fiscal 2026 (March 31, 2026). That is 7.3% higher than the $100.17M of fiscal 2025. Figures as of 18 Nov 2026, 01:29 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2026
$107.44M
Change on fiscal 2025
+7.3%
Growth, 5 years
−8.8% a year
Highest on record
$481.40Mfiscal 2023
Lowest on record
$53.99Mfiscal 2024
Fiscal years on record
62021–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Roivant Sciences total debt, in more detail

Over the five fiscal years to 2026 total debt shrank at a compound 8.8% a year. Across the 6 fiscal years on record (2021–2026), the highest was $481.40M in fiscal 2023 and the lowest $53.99M in fiscal 2024.

Total debt was 0.0× shareholders' equity at the end of fiscal 2026.

History · 6 fiscal years

Total debt by fiscal year

Roivant Sciences total debt, year by year

Roivant Sciences (ROIV) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2026$107.44M 7.3% up0.0×
2025$100.17M 85.5% up0.0×
2024$53.99M 88.8% down0.0×
2023$481.40M 129.2% up0.4×
2022$210.03M 23.3% up0.1×
2021$170.28M—0.1×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Roivant Sciences and comparable companies
CompanyTotal debtFiscal year
Labcorp Holdings LH$6.53B2025
DexCom DXCM$1.39B2025
Koninklijke Philips PHG€7.81B2025
Roivant Sciences ROIV$107.44M2026
West Pharmaceutical Services WST$321.10M2025
Quest Diagnostics DGX$6.59B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ROIV

Roivant Sciences, figure by figure

Roivant Sciences (ROIV) overview: price, valuation and scorecardAll health care companies by market value

Roivant Sciences total debt: questions and answers

How much debt does Roivant Sciences have?

Roivant Sciences (ROIV) carried total debt of $107.44M at the end of fiscal 2026 (March 31, 2026). That is 7.3% higher than the $100.17M of fiscal 2025.

What is the growth rate of Roivant Sciences's total debt?

Over the five fiscal years to 2026 total debt shrank at a compound 8.8% a year.

What are the highest and lowest total debt figures on record for Roivant Sciences?

Across the 6 fiscal years on record (2021–2026), the highest was $481.40M in fiscal 2023 and the lowest $53.99M in fiscal 2024.

How does Roivant Sciences's debt compare with its equity?

Total debt was 0.0× shareholders' equity at the end of fiscal 2026.

How is Roivant Sciences's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Roivant Sciences (ROIV) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/ROIV/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.